Salarius Pharmaceuticals rises on market strength
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 21 2025
0mins
Should l Buy ?
Source: 8-K
Salarius Pharmaceuticals Inc. shares increased by 9.97% as the stock crossed above its 20-day SMA, reflecting positive momentum in the market.
This movement is attributed to broad market strength, with the Nasdaq-100 up 0.06% and the S&P 500 up 0.01%. The overall market conditions have created a favorable environment for stocks like Salarius Pharmaceuticals, contributing to its upward price movement.
The rise in Salarius Pharmaceuticals' stock price indicates growing investor confidence, which may lead to increased interest in the company's future developments and potential projects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
